Tops & Flops Stocks
Security ▲ | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Elanco Animal Health Inc. | -0.240% | -3.536% | -23.480% | 36.401% | -6.376% | -57.150% | - |
Electrocore Inc. | - | - | - | - | - | - | - |
Eledon Pharmaceuticals Inc. | -2.680% | -1.802% | -17.424% | 77.236% | 32.927% | -66.202% | -84.473% |
Eli Lilly Corp. | 1.310% | 3.166% | 8.330% | 119.808% | 64.773% | 337.076% | 815.693% |
Elite Pharmaceut. | -4.110% | - | - | - | - | - | - |
Emergent Biosolutions Inc. | 8.190% | 33.525% | 66.963% | 47.644% | 338.689% | -80.599% | -76.645% |
Enanta Pharmaceuticals Inc. | 0.760% | 9.016% | 9.016% | -22.674% | 51.136% | -62.849% | -82.267% |
Endocyte Inc. | - | - | - | - | - | - | - |
Endo International | -16.670% | - | - | - | - | - | - |
Endologix | - | - | - | - | - | - | - |
Energizer Holdings Inc | 3.010% | 0.735% | 5.385% | -9.272% | -4.196% | -23.034% | - |
Ensign Group Inc. | 1.650% | 5.128% | 9.821% | 42.197% | 19.417% | - | - |
Enzo Biochem. Inc. | 2.050% | 8.152% | -8.716% | -25.746% | -19.106% | -62.311% | -69.967% |
Enzon Pharmaceuticals | -0.830% | -0.826% | 10.092% | -23.567% | 70.213% | -76.000% | -37.533% |
Epizyme Inc. | - | - | - | - | - | - | - |
Esperion Therapeutis.Inc. | 1.790% | 1.374% | -14.664% | 55.790% | -20.314% | -85.607% | -94.529% |
Evofem Biosciences Inc. | - | - | - | - | - | - | - |
Evoke Pharma Inc. | 1.640% | 0.813% | -2.745% | -67.368% | -47.513% | -95.672% | -94.627% |
Evolent Health Inc | 3.430% | -0.549% | -15.421% | -29.845% | -40.066% | - | - |
Evolus Inc | 7.070% | 8.163% | -2.752% | 61.832% | 17.127% | -1.852% | - |
Exact Sciences | 2.570% | 3.429% | 9.108% | -51.222% | -37.947% | -56.589% | -58.374% |
Exelixis Inc. | -2.360% | 0.834% | 0.686% | 15.644% | -6.079% | 35.286% | 10.650% |
EyeGate Pharmaceuticals Inc | 1.310% | - | - | - | - | - | - |
EyePoint Pharmaceuticals Inc. | 1.910% | 20.955% | 9.826% | 14.193% | -55.710% | 40.415% | - |
Fate Therapeutics Inc. | 8.450% | 7.388% | -10.561% | -29.490% | -12.120% | -95.890% | - |